Tacrolimus-Induced Thrombotic Microangiopathy (TMA) Complicated by Anamnestic Donor-Specific Antibodies Post-Kidney Transplantation

被引：0
|
作者：
Ibrahim, M. M. [1 ]
Manli, S. [2 ]
Kareem, S. [3 ]
Delos Santos, R. [4 ]
Alhamad, T. [4 ]
Liu, C. [2 ]
机构：
[1] Univ Maryland, Dept Med, Div Nephrol, Baltimore, MD 21201 USA
[2] Washington Univ St Louis, Dept Pathol, St Louis, MO USA
[3] Univ Buffalo, Div Nephrol, Dept Med, Buffalo, NY USA
[4] Washington Univ St Louis, Div Nephrol, Dept Med, St Louis, MO USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2023年 / 23卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
A37
引用
收藏
页码：S629 / S629
页数：1
相关论文
共 50 条
  • [41] Donor-Specific HLA Antibodies in a Cohort Comparing Everolimus with Cyclosporine After Kidney Transplantation
    Liefeldt, L.
    Brakemeier, S.
    Glander, P.
    Waiser, J.
    Lachmann, N.
    Schoenemann, C.
    Zukunft, B.
    Illigens, P.
    Schmidt, D.
    Wu, K.
    Rudolph, B.
    Neumayer, H. -H.
    Budde, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (05) : 1192 - 1198
  • [42] CLINICAL IMPACTS OF DESENSITIZATION FOR PRETRANSPLANT FCXM(-) DONOR-SPECIFIC HLA ANTIBODIES(+) KIDNEY TRANSPLANTATION
    Song, Eun Y.
    Kim, Suh M.
    Kim, Sang J.
    Park, Myoung H.
    Kim, Yon S.
    Ahn, Curie
    Ha, Jongwon
    Min, Sang-Il
    TRANSPLANT INTERNATIONAL, 2013, 26 : 79 - 79
  • [43] RE: Donor-specific HLA antibodies: Risk factors and outcomes after kidney transplantation
    Nunes, A. A.
    de Mello, Luane Marques
    TRANSPLANTATION PROCEEDINGS, 2013, 45 (01) : 446 - 447
  • [44] The Impact of Tacrolimus IPV and TTR on the Development of De Novo Donor-specific Antibodies in Kidney Transplant Recipients
    Xu, D.
    Richards, K.
    Zheng, K.
    Patel, H.
    Cardarelli, F.
    Pena, J. A.
    Aala, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 844 - 844
  • [45] Lower tacrolimus exposure and time in therapeutic range increase the risk of de novo donor-specific antibodies in the first year of kidney transplantation
    Davis, Scott
    Gralla, Jane
    Klem, Patrick
    Tong, Suhong
    Wedermyer, Gina
    Freed, Brian
    Wiseman, Alexander
    Cooper, James E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 (04) : 907 - 915
  • [46] Impact of Low Dose Donor-Specific HLA Antibodies in Living and Deceased Donor Kidney Transplantation.
    Lee, H.
    Sun, I.
    Yang, C.
    Chung, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 803 - 803
  • [47] Change in Estimated Glomerular Filtration Rate Pre and Post Development of Donor-Specific Antibodies after Kidney Transplantation.
    Ho, B.
    Montag, S.
    Bhagat, H.
    Atiemo, K.
    Daud, A.
    Kang, R.
    Zhao, L.
    Schwartz, J.
    Ladner, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 918 - 919
  • [48] Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation
    Hourmant, M
    Cesbron-Gautier, A
    Terasaki, PI
    Mizutani, K
    Moreau, A
    Meurette, A
    Dantal, J
    Giral, M
    Blancho, G
    Cantarovich, D
    Karam, G
    Follea, G
    Soulillou, JP
    Bignon, JD
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (09): : 2804 - 2812
  • [49] OUTCOMES FOLLOWING LIVING DONOR KIDNEY TRANSPLANTATION IN PATIENTS WITH DONOR-SPECIFIC HLA ANTIBODIES AFTER DESENSITIZATION WITH IMMUNOADSORPTION
    Kaelble, Florian
    da Silva, Luiza Pego
    Schaier, Matthias
    Zeier, Martin
    Mehrabi, Arianeb
    Suesal, Caner
    Morath, Christian
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 : 1582 - 1582
  • [50] Successful AB0-Incompatible Living Donor Kidney Transplantation in a Patient with Donor-Specific HLA Antibodies
    Guberina, H.
    Heinemann, F. M.
    Heinold, A.
    Lindemann, M.
    Eisenberger, U.
    Horn, P. A.
    Witzke, O.
    TRANSFUSIONSMEDIZIN, 2013, 3 (04) : 191 - 195
12345